Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Dec 1;27(12):1255-1256.
doi: 10.5551/jat.ED133. Epub 2020 Jun 4.

Polygenic Architecture of Common Severe Hypertriglyceridemia

Takashi Yamamoto  1 , Takanari Gotoda  1
Affiliations
Editorial

Polygenic Architecture of Common Severe Hypertriglyceridemia

Takashi Yamamoto et al. J Atheroscler Thromb. .
No abstract available

Keywords: Exome; Gene variant; Mutation; Next-generation sequencing; Type V hyperlipidemia.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Fig. 1.
Fig. 1.
Distribution of the rare (< 1% allele frequency) and common (> 1%) disease-causing gene variants identified by Matsunaga et al. in 23 Japanese patients with severe hypertriglyceridemia (fasting TG > 1,000 mg/dL, 11.29 mmol/L). The disease-causing variants were those identified by in silico predictions or reported previously of pathogenic significance (see text)8).
See this image and copyright information in PMC

References

    1. Fredrickson DS, Lees RS: Familial hyperlipoproteinemia. in The Metabolic Basis of Inherited Disease (ed. by Stanbury JB, Wyngaarden JB, Fredrickson DS.), 2nd ed., New York, McGraw-Hill, 1966, pp429
    1. Brown WV, Gaudet D, Goldberg I, Hegele R: Roundtable on etiology of familial chylomicronemia syndrome. J Clin Lipidol, 2018; 12: 5-11 - PubMed
    1. Brunzell JD, Deeb SS: Familial lipoprotein lipase deficiency, apoC-II deficiency and hepatic lipase deficiency. in The Metabolic and Molecular Bases of Inherited Disease (ed. by Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B.), 8th ed., New York, McGraw-Hill, 2000, pp2789-2816
    1. Surendran RP, Visser ME, Heemelaar S, Wang J, Peter J, Defesche JC, Kuivenhoven JA, Hosseini M, Péterfy M, Kastelein JJ, Johansen CT, Hegele RA, Stroes ES, Dallinga-Thie GM: Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia. J Intern Med, 2012; 272: 185-196 - PMC - PubMed
    1. Gotoda T, Shirai K, Ohta T, Kobayashi J, Yokoyama S, Oikawa S, Bujo H, Ishibashi S, Arai H, Yamashita S, Harada-Shiba M, Eto M, Hayashi T, Sone H, Suzuki H, Yamada N: Diagnosis and management of type I and type V hyperlipoproteinemia. J Atheroscler Thromb, 2012; 19: 1-12 - PubMed

Publication types